Molecular analysis of HLA-H gene mutations in New Zealand patients with haemochromatosis

New Zealand Medical Journal

Volumn 110, Issue 1056, 1997, Pages 429-432

  Burt, Michael J ^a,b   Upton, Jeff D ^b   Morison, Ian M ^c   Chapman, Bruce A ^b   Faed, Jim M ^d   George, Peter M ^b  

^a Department of Gastroenterology ^*  (New Zealand)

^b CHRISTCHURCH HOSPITAL   (New Zealand)

^c Southern Community Laboratories   (New Zealand)

^d DUNEDIN HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; HFE PROTEIN, HUMAN; HLA ANTIGEN; HLA ANTIGEN CLASS 1; MEMBRANE PROTEIN; TYROSINE;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; FEMALE; GENE FREQUENCY; GENETICS; HEMOCHROMATOSIS; HOMOZYGOTE; HUMAN; MALE; MIDDLE AGED; MUTATION; NEW ZEALAND; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; RESTRICTION MAPPING;

ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SUBSTITUTION; CYSTEINE; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HOMOZYGOTE; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION; NEW ZEALAND; POLYMERASE CHAIN REACTION; RESTRICTION MAPPING; TYROSINE;

EID: 0031589623     PISSN: 00288446     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Powell LW, Isselbacher KJ. Hemochromatosis. In: Isselbacher KJ, Braunwald E, Wilson JD, et al, editors. Harrison's principles of internal medicine. 13 ed. New York: McGraw-Hill; 1994. p 2069-73.
2. Niederau C, Fischer R, Purschel A, et al. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 1996; 110: 1107-19.
3. Niederau C, Fischer R, Sonnenberg A, et al. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med 1985; 313: 1256-62.
4. Fargion S, Mandelli C, Piperno A, et al. Survival and prognostic factors in 212 Italian patients with genetic hemochromatosis. Hepatology 1992; 15: 655-9.
5. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class 1-like gene is mutated in patients with hereditary hemochromatosis. Nat Genet 1996; 13: 399-408.
6. Beutler E, Gelbart T, West C, et al. Mutation analysis in hereditary hemochromatosis. Blood Cells Mol Dis 1996; 22: 187-94.
7. Jazwinska EC, Cullen LM, Busfield F, et al. Haemochromatosis and HLA-H. Nat Genet 1996; 14: 249-51.
8. Jouanolle AM, Gandon G, Jezequel P, et al. Haemochromatosis and HLA-H Nat Genet 1996; 14: 251-2.
9. Beutler E. Genetic irony beyond haemochromatosis: clinical effects of HLA-H mutations. Lancet 1997; 349: 296-7.
10. Scheuer PJ. Cirrhosis. In: MacSween RNM, Anthony PP, Scheuer PJ, editors. Pathology of the liver. New York: Churchill Livingstone, 1979. p185.
11. Crawford DHG, Powell LW, Leggett BA, et al. Evidence that the ancestral haplotype in Australian hemochromatosis patients may be associated with a common mutation in the gene. Am J Hum Genet 1995; 57; 362-7.
12. Talmud P, Tybjaerg-Hansen A, Bhatnagar D, et al. Rapid screening for specific mutations in patients with a clinical diagnosis of familial hypercholesterolaemia. Atherosclerosis 1991; 89: 137-41.
13. Jazwinska EC, Powell LW. Hemochromatosis and "HLA-H" definite. Hepatology 1997: 25; 495-6.
14. Chapman BA, Horton DM, Burt MJ, et al. Investigation of subjects with abnormal iron studies: role of the hepatic iron index. NZ Med J 1994; 107: 504-7.
15. Edwards CQ, Kushner JP. Screening for hemochromatosis. N Engl J Med 1993; 328; 1616-20.